Small volume
A single drop of blood
Fast & easy
15 minute operation
Lab Quality
>95% correlation with lab results
Instrument-free
USB-C dongle included
Launch Party
Please join us for our launch party on December 14th, 2024 in Carlsbad!We will unveil our microchip blood test for measuring kidney function from a finger-stick. Alongside our existing ALT+AST liver indications, this milestone represents the next step in our relentless pursuit to provide comprehensive blood testing from a drop of blood.RSVP here.
Technology
InD has developed the first disposable lab-quality spectrophotometer for use in any setting from a drop of blood.All of our devices are proudly developed & manufactured in Carlsbad, California.
Data
n=45 samples of whole blood from mice over multiple lots & multiple days
Products
For research and veterinary use only
quic ALT
Alanine
Aminotransferase
20 count
$500
quic AST
Aspartate
Aminotransferase
20 count
$500
quic ALT + AST
Alanine Aminotransferase &
Aspartate Aminotransferase
20 count
$600
Android/PC dongle
Comes with 2 cables to connect with your phone or PC
$50
Under development
quic BUN
Blood urea nitrogen
(Under Development)
quic CREA
Creatinine
(Under Development)
quic BUN + CREA
Blood urea nitrogen + Creatinine
(Under Development)
Iphone dongle
Comes with 2 cables to connect with your Apple devices
Our mission
Our mission is to retrieve vital health information from a drop of blood using digital microchips
Leadership
Octavian Florescu, CEO
Octavian has spent more than 20 years developing microchip-based Point-of-Care devices. He received his PhD from UC Berkeley in Electrical Engineering and his BSc in Computer Engineering from University of Waterloo. In his free time, he loves to ski and surf.
Ana Florescu, COO
With a background in finance, entrepreneurship, and innovation, Ana handles operations and business development at InD. She loves coordinating conference exhibits and connecting with veterinarians across the country.
Advisors
W. Frank Peacock IV, MD, FACEP, FACC
Professor of Emergency Medicine and Vice Chair for Research in the department of Emergency Medicine at Baylor College of Medicine, in Houston, Texas
Clint Severson
Clint Severson was CEO of Abaxis from 1995 until its sale in 2018 for $2B to Zoetis. He grew the company from $6M in sales to over $300M.
Erica Behling-Kelly, DVM, PhD, DACVP
Chief Medical Officer,Ellie Diagnostics
Austin Viall, DVM
Associate Professor, Pathology, Microbiology & ImmunologyUC Davis
Associate Professor, Pathology, Microbiology & Immunology
UC Davis